Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting
Paul Spearman(Cincinnati Children's Hospital Medical Center), GD Tomaras, Edgar T. Overton(University of Alabama at Birmingham), Marnie Elizaga(Fred Hutch Cancer Center), Ying Huang(Fred Hutch Cancer Center), Michael Pensiero(National Institute of Allergy and Infectious Diseases), Laissa Ouedraogo(National Institutes of Health), Hasan Ahmed(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Spyros A. Kalams(Vanderbilt University Medical Center), Christopher Butler(University of Oxford), M. Juliana McElrath(Fred Hutch Cancer Center), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), SW Barnett(Novartis (United States)), D Montefiori
Cited by 3
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
|New England Journal of Medicine|2013|586